Salem Erode Investments rights issue sees 102% subscription
- Salem Erode Investments Limited finalized its rights issue allotment with a subscription rate of 102.47%
- The company raised up to ₹2,293.10 lakh through the issuance of 1,14,65,520 equity shares at ₹20 each
- Valid applications totaled 302, with 231 initial applications rejected due to technical reasons
- Trading of the newly allotted shares is scheduled to commence on or before October 8, 2026

*this image is generated using AI for illustrative purposes only.
Salem Erode Investments Limited has finalized the basis of allotment for its rights issue, which received valid applications amounting to 102.47% of the offered equity shares. The company raised up to ₹2,293.10 lakh by issuing fully paid-up equity shares at a price of ₹20 each.
The issue opened for subscription on September 15, 2026, and closed on October 1, 2026. Out of the total 533 applications received for 1,17,86,899 rights equity shares, 231 applications were rejected due to technical reasons. This left 302 valid applications for 1,17,48,413 rights equity shares, exceeding the total number of shares allotted under the issue.
Allotment details
The Board of Directors approved the allotment of rights equity shares to successful applicants on October 5, 2026. The allotment was finalized in consultation with the Registrar to the Issue and BSE, the designated stock exchange. No rights equity shares have been kept in abeyance.
| Category | Valid applications | Rights shares applied | Rights shares allotted |
|---|---|---|---|
| Eligible Equity Shareholders | 223 | 56,17,455 | 56,17,455 |
| Renouncees | 79 | 61,30,958 | 58,48,065 |
| Total | 302 | 1,17,48,413 | 1,14,65,520 |
Subscription analysis
The subscription level indicates strong participation from both existing shareholders and renouncees. Eligible equity shareholders accounted for 73.84% of the valid applications, while renouncees contributed 26.16%. The total value of rights equity shares applied for stood at ₹23,49,68,260, compared to the allotted value of ₹22,93,10,400 (calculated as 1,14,65,520 shares at ₹20).
What the Numbers Show
The data reveals a slight divergence between application volume and final allotment. While 302 valid applications sought 1,17,48,413 shares, only 1,14,65,520 shares were allotted. This difference of 2,82,893 shares suggests that some additional bids from renouncees were partially rejected or scaled down during the allotment process, as the total applied shares exceeded the total offered shares by approximately 2.47%. The high number of technical rejections (231 out of 533) also highlights potential procedural hurdles for retail applicants using the ASBA mechanism.
Listing and trading timeline
The dispatch of allotment advice cum unlocking intimation to investors commenced and completed on October 6, 2026. Instructions to self-certified syndicate banks (SCSBs) for unblocking funds in ASBA applications were issued on October 5, 2026. The listing application was filed with stock exchanges on October 5, 2026, and BSE granted listing approval on October 6, 2026.
The credit of rights equity shares in dematerialized form to respective demat accounts of allottees was completed on October 6, 2026. Upon receipt of trading approvals, the rights equity shares are expected to commence trading on or before October 8, 2026, under the same ISIN as existing equity shares. Investors are advised that these shares can be traded only in dematerialized form.
Historical Stock Returns for Salem Erode Investments
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -7.66% | -17.34% | -20.79% | -17.57% | 0.0% | +366.97% |
How will Salem Erode Investments deploy the ₹2,293.10 lakh raised from the rights issue to impact its future capital expenditure or debt reduction strategies?
What is the expected short-term price volatility for the stock upon its listing on October 8, given the 102.47% oversubscription and dilution effects?
Will the high rate of technical rejections (43% of applications) prompt the company or exchanges to implement stricter investor education or system upgrades for future ASBA-based issues?

































